JP2011514358A - 改良された経粘膜組成物および剤形 - Google Patents

改良された経粘膜組成物および剤形 Download PDF

Info

Publication number
JP2011514358A
JP2011514358A JP2010550703A JP2010550703A JP2011514358A JP 2011514358 A JP2011514358 A JP 2011514358A JP 2010550703 A JP2010550703 A JP 2010550703A JP 2010550703 A JP2010550703 A JP 2010550703A JP 2011514358 A JP2011514358 A JP 2011514358A
Authority
JP
Japan
Prior art keywords
osmotic pressure
mos
transmucosal
dosage form
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010550703A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011514358A5 (enExample
Inventor
ホール、リチャード、ジェイ．
レンツ、マシュー、ジェイ．
Original Assignee
セファロン、インク．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by セファロン、インク． filed Critical セファロン、インク．
Publication of JP2011514358A publication Critical patent/JP2011514358A/ja
Publication of JP2011514358A5 publication Critical patent/JP2011514358A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
JP2010550703A 2008-03-14 2009-03-13 改良された経粘膜組成物および剤形 Pending JP2011514358A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6941408P 2008-03-14 2008-03-14
PCT/US2009/001626 WO2009114192A2 (en) 2008-03-14 2009-03-13 Enhanced transmucosal composition and dosage form

Publications (2)

Publication Number Publication Date
JP2011514358A true JP2011514358A (ja) 2011-05-06
JP2011514358A5 JP2011514358A5 (enExample) 2013-05-16

Family

ID=41065734

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010550703A Pending JP2011514358A (ja) 2008-03-14 2009-03-13 改良された経粘膜組成物および剤形

Country Status (6)

Country Link
US (1) US20110021583A1 (enExample)
EP (1) EP2265250A2 (enExample)
JP (1) JP2011514358A (enExample)
CA (1) CA2717984C (enExample)
MX (1) MX2010009961A (enExample)
WO (1) WO2009114192A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3316865A4 (en) 2015-07-02 2019-01-23 Civitas Therapeutics, Inc. TRIPTAN POWDER FOR PULMONARY ADMINISTRATION
CA3166250A1 (en) * 2020-02-05 2021-08-12 Gregory G. Plucinski Drug products for intranasal administration and uses thereof
WO2026050777A2 (en) * 2024-09-01 2026-03-05 Sandipkumar Patel Stable liquid formulations of frovatriptan

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11292787A (ja) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd 生理活性ペプチドを含有する経粘膜投与製剤
JP2003512329A (ja) * 1999-10-20 2003-04-02 アルタナ ファルマ アクチエンゲゼルシャフト シクレソニド含有粘膜投与用医薬組成物
JP2004099624A (ja) * 1998-04-21 2004-04-02 Teijin Ltd 粘膜投与用医薬組成物
US20050084530A1 (en) * 1999-12-01 2005-04-21 Natco Pharma Limited Rapid acting freeze dried oral pharmaceutical composition for treating migraine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968507A (en) * 1984-06-20 1990-11-06 Merck & Co., Inc. Controlled porosity osmotic pump
US6255502B1 (en) * 1996-07-11 2001-07-03 Farmarc Nederland B.V. Pharmaceutical composition containing acid addition salt of basic drug
US6210699B1 (en) * 1999-04-01 2001-04-03 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
US20020147232A1 (en) * 2000-05-26 2002-10-10 Claus Sundgreen Pharmaceutical compositions comprising desglymidodrine as an active drug substance
WO2004093917A2 (en) * 2003-04-22 2004-11-04 Nastech Pharmaceutical Company Inc. Intranasal administration of triptans
US20060002989A1 (en) * 2004-06-10 2006-01-05 Ahmed Salah U Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
US20060193908A1 (en) * 2004-11-09 2006-08-31 Burnside Beth A Extended release formulations of poorly soluble antibiotics
WO2007096906A2 (en) * 2006-02-27 2007-08-30 Panacea Biotec Ltd. Novel buccoadhesive compositions and process of preparation thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11292787A (ja) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd 生理活性ペプチドを含有する経粘膜投与製剤
JP2004099624A (ja) * 1998-04-21 2004-04-02 Teijin Ltd 粘膜投与用医薬組成物
JP2003512329A (ja) * 1999-10-20 2003-04-02 アルタナ ファルマ アクチエンゲゼルシャフト シクレソニド含有粘膜投与用医薬組成物
US20050084530A1 (en) * 1999-12-01 2005-04-21 Natco Pharma Limited Rapid acting freeze dried oral pharmaceutical composition for treating migraine

Also Published As

Publication number Publication date
CA2717984A1 (en) 2009-09-17
US20110021583A1 (en) 2011-01-27
WO2009114192A2 (en) 2009-09-17
EP2265250A2 (en) 2010-12-29
WO2009114192A3 (en) 2010-07-08
MX2010009961A (es) 2010-09-30
CA2717984C (en) 2013-11-26

Similar Documents

Publication Publication Date Title
US7910132B2 (en) Pharmaceutical composition for the treatment of acute disorders
TWI554498B (zh) 置入口腔的劑型
JP6158810B2 (ja) ブプレノルフィンの乱用抵抗性粘膜付着性送達デバイス
ES2536514T3 (es) Composiciones farmacéuticas de doble acción basadas en superestructuras de antagonista/bloqueador de receptores de angiotensina (ARB) y receptor de endopeptidasa neutra (NEP)
JP6209495B2 (ja) 上部消化管治療用医薬製剤
JP2017052782A (ja) 味覚マスキングのためのイオン交換樹脂を含有する可食性経口ストリップ又はウエハース剤形
KR20090080037A (ko) 점막 비점착성 필름 제형
TW201022253A (en) Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low pH and methods of use thereof
CN100594936C (zh) 改善透粘膜给药制剂的吸收的方法
CN105848648B (zh) 用于治疗食道的炎性病变的优化药物制剂
WO2007096906A2 (en) Novel buccoadhesive compositions and process of preparation thereof
JP5828609B2 (ja) 持続性解熱鎮痛消炎剤
JP4090997B2 (ja) ペリンドプリルの口内分散性薬剤組成物
JP5561885B2 (ja) ミルタザピンの新しい配合物
CA2717984C (en) Enhanced transmucosal composition and dosage form
TW200408409A (en) Oral administration of calcitonin
CN1218694C (zh) β－肾上腺素能激动剂在制备用于治疗子宫内膜异位症或不孕或提高生育力的药物中的应用
US20080242717A1 (en) Methods for treating benign prostatic hyperplasia
HUE030609T2 (en) New pharmaceutical compositions for the treatment of insomnia
CN113347975B (zh) 用于治疗侵蚀性手骨关节炎的孟鲁司特
TWI222883B (en) Pharmaceutical mixture comprising a combination of a profen and other active compounds
US20100016363A1 (en) Fixed Combination Dosage Forms for the Treatment of Migraine
JP5435659B2 (ja) トリプタンの経口腔粘膜投与用製剤形態
US20130143912A1 (en) Sublingual zolpidem formulations
ES3036600T3 (en) Mucoadhesive tablet for the treatment of oropharyngeal fungal infections

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120313

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120313

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130515

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131008

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140108

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140116

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140208

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140218

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140610